UMIN ID: UMIN000001918
Registered date:01/05/2009
Prevention of early asthma in childhood trial with pranlukast in Mie; PROACT-Mie
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Wheezing syndrome in infants |
Date of first enrollment | 2005/11/01 |
Target sample size | 100 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | pranlukast and as-needed beta agonists as-needed beta agonists |
Outcome(s)
Primary Outcome | wheezing episodes during and after treatment with pranlukast |
---|---|
Secondary Outcome | rate of dropout because of persistent asthma symptoms |
Key inclusion & exclusion criteria
Age minimum | 6months-old |
---|---|
Age maximum | 24months-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Wheezing due to congenital anatomical anomaly, wheezing due to mediatinal neoplasm, croup syndrome, foreign body in the airways, heart diseases, pneumonia, tuberculosis, administration of leukotriene receptor antagonists, cromolyns, anti-histamines, severe liver/renal/heart diseases |
Related Information
Primary Sponsor | Study group of pediatric asthma in Mie prefecture |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Mie National Hospital |
Secondary ID(s) |
Contact
public contact | |
Name | Yuki Yamamoto |
Address | 357 Osato-kubota, Tsu, Mie, Japan Japan |
Telephone | 059-245-6355 |
fujisawa@mie-m.hosp.go.jp | |
Affiliation | Mie National Hospital Department of clinical trials |
scientific contact | |
Name | Takao Fujisawa |
Address | 357 Osato-kubota, Tsu, Mie, Japan Japan |
Telephone | 059-245-6355 |
Affiliation | Mie National Hospital Institute for clinical research |